Unither Pharmaceuticals is a global development and contract manufacturing organisation specialising in single-unit doses. The company’s technology offering includes blow-fill-seal, liquid stick-packs, powder stick-packs, tablets, pharmaceutical bottles, suppositories and pessaries.
Unither Pharmaceuticals is a global contract development and manufacturing partner for proprietary and generic pharmaceutical dosage forms. Its focus is single unit dose technologies with an emphasis on affordable, portable, and easy-to-use solutions. Its technologies include:
- Blow-fill-seal (BFS) technology for sterile unit-doses
- Liquid liquid Stick-Pack technology
- Powder powder Stick-Pack technology
- Effervescent improved dry formulations
- Patented drug delivery systems for per-buccal mucous administration
Unither was founded in 1993, and is owned privately, including by management and private equity companies (such as Keensight Capital, Paris, France). Unither has ten facilities globally, including six manufacturing sites in France, the US and Brazil, an R&D centre in France, and a sales subsidiary in China. It has developed and manufactured products sold in over 100 countries and has partnered with numerous pharmaceutical companies.